Supplementary Table 4 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1

Supplementary Table 4 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1

<p>Immunohistology: Response at time of biopsy, tissue, date biopsies, previous CPI and protocol CPI, elapse times, TILs and macrophages phenotypes.</p>

Enregistré dans:
Détails bibliographiques
Auteur principal: Caroline Robert (15032672) (author)
Autres auteurs: Céleste Lebbé (15053390) (author), Thierry Lesimple (15033111) (author), Eija Lundström (15053393) (author), Valérie Nicolas (15053396) (author), Bruno Gavillet (15053399) (author), Philippa Crompton (15053402) (author), Barouyr Baroudjian (15053405) (author), Emilie Routier (15053408) (author), Ferdy J. Lejeune (15053411) (author)
Publié: 2025
Sujets:
Cancer
Immuno-oncology
Immunotherapy
Checkpoint blockade
Combination immunotherapy
Skin Cancers
Melanoma
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires